Stock to Consider – Gilead Sciences, Inc.

GILD  As a replacement for Teva Pharmaceutical Industries, which was removed from the aggressive portfolio on Monday, I am adding biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD – $99.36) to the list. I will provide details on my thoughts for GILD in a future posting.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: